FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Phosphocol, p-32 15mCi injection suspension 10mL vial Chromic phosphate (32-P) only product in parenteral dose form
Phospholipase specific extract Product containing phospholipase (medicinal product)
Phospholipid + protein 35mg/0.65mg suspension Product containing only calfactant (medicinal product)
Phosphoric diester hydrolase Phosphoric diester hydrolase
Phosphoric monoester hydrolase Substance with phosphoric monoester hydrolase mechanism of action (substance)
Phosphorus-32(diagnostic) Product containing phosphorus-32 (medicinal product)
Phosphorus-oxygen lyase Phosphorus-oxygen lyase
Phosphotransferase Kinase
Photocoagulation of lesion of retina NEC Destruction of lesion of retina by photocoagulation
Photocoagulation of retina for detachment NOS Repair of retinal detachment by photocoagulation (procedure)
Photographer/cameraman NOS Photographer AND/OR cameraman
Photographer/cameraman NOS Photographer AND/OR cameraman
Photoptarmosis Photoptarmosis
Photorhabdus luminescens subspecies thracensis Photorhabdus temperata subspecies thracensis (organism)
Photosensitising drugs Drug or medicament (substance)
Phototherapy &/or radiation therapy Radiotherapy
Phthalic anhydride specific extract Phthalic anhydride
Phylum Thermomicrobia Class Thermomicrobia (organism)
Phylum acanthocephala Phylum Acanthocephala (organism)
Phylum microspora Phylum Microsporidia (organism)
Physical examination - action Examination - action
Physical exercise NOS Physical exercises
Physical exercise NOS Physical exercises
Physical medicine iontophoresis Iontophoresis procedure
Physical medicine service Physical medicine service (qualifier value)
Physical science technician Physics technician
Physical scientist NOS Physical scientist
Physical scientist NOS Physical scientist
Physical/nutrit. assess NOS Assessment of nutritional status
Physical/nutrit. assess NOS Assessment of nutritional status
Physician service Physician service (qualifier value)
Physics - other therapy Therapy
Physics - other therapy Therapy
Physics - other therapy NOS Therapy
Physics - other therapy NOS Therapy
Physics-other measurements NOS Physics - other measurements
Physics-other measurements NOS Physics - other measurements
Physics: diagn. methods NOS Evaluation procedure (procedure)
Physics: diagnostic methods NOS Evaluation procedure (procedure)
Physics: other diagn. methods Evaluation procedure (procedure)
Physics: other diagnostic methods Evaluation procedure (procedure)
Physiol. function test NOS Physiological function tests
Physiol. function test NOS Physiological function tests
Physiological functions and activities Functional status document section (record artifact)
Physiological jaundice (& [NOS]) Newborn physiological jaundice
Physostigmine 0.25% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine 0.5% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.25%+2% eye drops Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
Physostigmine+pilocarpine 0.25%+4% eye drops Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine+pilocarpine 0.5%+4% eye drops Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug)
Pichia ohmeri Kodamaea ohmeri (organism)
Pick's cell Niemann-Pick cell
Picornavirus Family Picornaviridae (organism)
Pigeon droppings protein Pigeon droppings
Pigmented nevus, no International Classification of Diseases for Oncology subtype Pigmented nevus
Pigmented skin lesion of suspected malignant nature Suspected malignant pigmented skin lesion (situation)
Pigmented villonodular synovitis Diffuse tenosynovial giant cell tumor
Pigmented villonodular synovitis Diffuse tenosynovial giant cell tumor
Pigmenting agent Pigment
Pigmenting agent Pigment
Pilocarpine hydrochloride 10% eye drops Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug)
Pilocarpine hydrochloride 5.0mg tablet Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)
Pilocarpine nitrate 1% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 1% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 2% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% conventional release eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocarpine nitrate 4% single-use eye drops Product containing only pilocarpine in ocular dose form (medicinal product form)
Pilocytic astrocytoma Pilocytic astrocytoma
Pilonidal cyst with no abscess Pilonidal cyst
Pink color Pink color (qualifier value)
Pioglitazone 15mg + metformin 1g m/r tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g m/r tablet Metformin and pioglitazone only product in oral dose form
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet Metformin and pioglitazone only product in oral dose form
Pipe/sheet metal worker NOS Pipe/sheet/structural metal worker
Pipe/sheet metal worker NOS Pipe/sheet/structural metal worker
Piperacillin 1g powder for injection solution vial Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin 2g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial
Piperacillin 3g injection (pdr for recon) Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin 4g infusion set Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin 4g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin 4g/tazobactam 500mg powder and solvent for infusion vial Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin sodium + tazobactam sodium ns/ns injection Product containing piperacillin and tazobactam (medicinal product)
Piperacillin sodium 3g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial
Piperacillin sodium 4g powder for injection solution vial Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperazine+sennosides 4g/15.3mg/sachet oral powder Product containing only piperazine and sennoside (medicinal product)
Piperidolate hydrochloride adverse reaction Adverse reaction to piperidolate (disorder)
Piple cumanesis cumanesis Aburria cumanensis subspecies cumanensis (organism)
Pirbuterol acetate 0.2mg aerosol Product containing only pirbuterol (medicinal product)
Piringer's lymphadenitis Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome Lymphadenitis caused by Toxoplasma gondii (disorder)
Piringer-Kuchinka's syndrome Lymphadenitis caused by Toxoplasma gondii (disorder)
Piroxicam 10mg dispersible tablet Piroxicam 10 mg oral tablet
Piroxicam 20mg conventional release orodispersible tablet Piroxicam 20 mg oral tablet
Piroxicam 20mg dispersible tablet Piroxicam 20 mg oral tablet
Piroxicam 20mg melt tablet Piroxicam 20 mg oral tablet
Pitt Hopkins-like syndrome CNTNAP2-related developmental and epileptic encephalopathy
Pituitary adenoma, no International Classification of Diseases for Oncology subtype Benign pituitary adenoma (morphologic abnormality)
Pituitary hypothyroidism Secondary hypothyroidism

Start Previous Page 150 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start